nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A4—Crohn's disease	0.458	0.571	CbGaD
Ofloxacin—SLC22A5—Crohn's disease	0.344	0.429	CbGaD
Ofloxacin—ABCC2—Sulfasalazine—Crohn's disease	0.0367	1	CbGbCtD
Ofloxacin—SLC22A4—Organic cation transport—SLC22A5—Crohn's disease	0.00443	0.173	CbGpPWpGaD
Ofloxacin—SLC22A5—Organic cation transport—SLC22A4—Crohn's disease	0.00333	0.13	CbGpPWpGaD
Ofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00301	0.117	CbGpPWpGaD
Ofloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00226	0.088	CbGpPWpGaD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00171	0.0664	CbGpPWpGaD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00171	0.0664	CbGpPWpGaD
Ofloxacin—TOP2A—Methyldopa—Mesalazine—Crohn's disease	0.00126	0.766	CbGdCrCtD
Ofloxacin—Sparfloxacin—SLC22A5—Crohn's disease	0.0012	0.266	CrCbGaD
Ofloxacin—Levofloxacin—SLC22A4—Crohn's disease	0.00113	0.249	CrCbGaD
Ofloxacin—Lomefloxacin—SLC22A5—Crohn's disease	0.000991	0.219	CrCbGaD
Ofloxacin—Norfloxacin—SLC22A5—Crohn's disease	0.000687	0.152	CrCbGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000602	0.0234	CbGpPWpGaD
Ofloxacin—Gatifloxacin—ALB—Crohn's disease	0.000511	0.113	CrCbGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000453	0.0176	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000405	0.0158	CbGpPWpGaD
Ofloxacin—TOP2A—Methyltestosterone—Prednisone—Crohn's disease	0.000386	0.234	CbGdCrCtD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000375	0.0146	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000342	0.0133	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000342	0.0133	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—CREM—Crohn's disease	0.00031	0.0121	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000301	0.0117	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000282	0.011	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000274	0.0107	CbGpPWpGaD
Ofloxacin—Pancytopenia—Mesalazine—Crohn's disease	0.000261	0.00202	CcSEcCtD
Ofloxacin—Dysuria—Mesalazine—Crohn's disease	0.000257	0.00199	CcSEcCtD
Ofloxacin—Neutropenia—Mesalazine—Crohn's disease	0.000257	0.00199	CcSEcCtD
Ofloxacin—Viral infection—Prednisone—Crohn's disease	0.000256	0.00199	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000255	0.00198	CcSEcCtD
Ofloxacin—Arthropathy—Prednisone—Crohn's disease	0.000255	0.00198	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000254	0.00197	CcSEcCtD
Ofloxacin—Pollakiuria—Mesalazine—Crohn's disease	0.000254	0.00197	CcSEcCtD
Ofloxacin—Agranulocytosis—Azathioprine—Crohn's disease	0.000251	0.00195	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000251	0.00194	CcSEcCtD
Ofloxacin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00025	0.00194	CcSEcCtD
Ofloxacin—Weight decreased—Mesalazine—Crohn's disease	0.000249	0.00193	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000248	0.00193	CcSEcCtD
Ofloxacin—Leukocytosis—Prednisone—Crohn's disease	0.000246	0.00191	CcSEcCtD
Ofloxacin—Pneumonia—Mesalazine—Crohn's disease	0.000246	0.00191	CcSEcCtD
Ofloxacin—Infestation—Mesalazine—Crohn's disease	0.000245	0.0019	CcSEcCtD
Ofloxacin—Infestation NOS—Mesalazine—Crohn's disease	0.000245	0.0019	CcSEcCtD
Ofloxacin—Ulcer—Prednisone—Crohn's disease	0.000245	0.0019	CcSEcCtD
Ofloxacin—Cataract—Prednisone—Crohn's disease	0.000243	0.00189	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000243	0.00188	CcSEcCtD
Ofloxacin—Haemoglobin—Azathioprine—Crohn's disease	0.000243	0.00188	CcSEcCtD
Ofloxacin—Haemorrhage—Azathioprine—Crohn's disease	0.000241	0.00187	CcSEcCtD
Ofloxacin—Renal failure—Mesalazine—Crohn's disease	0.000241	0.00187	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00024	0.00186	CcSEcCtD
Ofloxacin—Stomatitis—Mesalazine—Crohn's disease	0.000239	0.00185	CcSEcCtD
Ofloxacin—Jaundice—Mesalazine—Crohn's disease	0.000239	0.00185	CcSEcCtD
Ofloxacin—Conjunctivitis—Mesalazine—Crohn's disease	0.000238	0.00185	CcSEcCtD
Ofloxacin—Vasculitis—Prednisone—Crohn's disease	0.000237	0.00184	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—Crohn's disease	0.000236	0.0092	CbGpPWpGaD
Ofloxacin—Haematuria—Mesalazine—Crohn's disease	0.000234	0.00181	CcSEcCtD
Ofloxacin—Hiccups—Prednisone—Crohn's disease	0.000232	0.0018	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000232	0.0018	CcSEcCtD
Ofloxacin—Epistaxis—Mesalazine—Crohn's disease	0.000231	0.00179	CcSEcCtD
Ofloxacin—Sinusitis—Mesalazine—Crohn's disease	0.00023	0.00178	CcSEcCtD
Ofloxacin—Agranulocytosis—Mesalazine—Crohn's disease	0.000229	0.00177	CcSEcCtD
Ofloxacin—Erythema multiforme—Azathioprine—Crohn's disease	0.000228	0.00177	CcSEcCtD
Ofloxacin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000228	0.00176	CcSEcCtD
Ofloxacin—Skin exfoliation—Prednisone—Crohn's disease	0.000221	0.00172	CcSEcCtD
Ofloxacin—Haemoglobin—Mesalazine—Crohn's disease	0.000221	0.00171	CcSEcCtD
Ofloxacin—Rhinitis—Mesalazine—Crohn's disease	0.00022	0.00171	CcSEcCtD
Ofloxacin—Hepatitis—Mesalazine—Crohn's disease	0.00022	0.00171	CcSEcCtD
Ofloxacin—Haemorrhage—Mesalazine—Crohn's disease	0.00022	0.00171	CcSEcCtD
Ofloxacin—Pharyngitis—Mesalazine—Crohn's disease	0.000218	0.00169	CcSEcCtD
Ofloxacin—Immune system disorder—Azathioprine—Crohn's disease	0.000218	0.00169	CcSEcCtD
Ofloxacin—Mediastinal disorder—Azathioprine—Crohn's disease	0.000218	0.00169	CcSEcCtD
Ofloxacin—Neuropathy—Prednisone—Crohn's disease	0.000217	0.00169	CcSEcCtD
Ofloxacin—Urinary tract disorder—Mesalazine—Crohn's disease	0.000217	0.00168	CcSEcCtD
Ofloxacin—Oedema peripheral—Mesalazine—Crohn's disease	0.000217	0.00168	CcSEcCtD
Ofloxacin—Chills—Azathioprine—Crohn's disease	0.000217	0.00168	CcSEcCtD
Ofloxacin—Connective tissue disorder—Mesalazine—Crohn's disease	0.000216	0.00168	CcSEcCtD
Ofloxacin—Arrhythmia—Azathioprine—Crohn's disease	0.000216	0.00167	CcSEcCtD
Ofloxacin—Urethral disorder—Mesalazine—Crohn's disease	0.000216	0.00167	CcSEcCtD
Ofloxacin—Alopecia—Azathioprine—Crohn's disease	0.000213	0.00165	CcSEcCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000213	0.00828	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000212	0.00164	CcSEcCtD
Ofloxacin—Oesophagitis—Prednisone—Crohn's disease	0.000212	0.00164	CcSEcCtD
Ofloxacin—Ecchymosis—Prednisone—Crohn's disease	0.000209	0.00162	CcSEcCtD
Ofloxacin—Erythema multiforme—Mesalazine—Crohn's disease	0.000208	0.00161	CcSEcCtD
Ofloxacin—Pulmonary oedema—Prednisone—Crohn's disease	0.000206	0.0016	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000206	0.00801	CbGpPWpGaD
Ofloxacin—Eye disorder—Mesalazine—Crohn's disease	0.000205	0.00159	CcSEcCtD
Ofloxacin—Tinnitus—Mesalazine—Crohn's disease	0.000205	0.00159	CcSEcCtD
Ofloxacin—Cardiac disorder—Mesalazine—Crohn's disease	0.000204	0.00158	CcSEcCtD
Ofloxacin—Hyperkinesia—Prednisone—Crohn's disease	0.000202	0.00157	CcSEcCtD
Ofloxacin—Sepsis—Prednisone—Crohn's disease	0.000201	0.00156	CcSEcCtD
Ofloxacin—Angiopathy—Mesalazine—Crohn's disease	0.000199	0.00155	CcSEcCtD
Ofloxacin—Euphoric mood—Prednisone—Crohn's disease	0.000199	0.00154	CcSEcCtD
Ofloxacin—Immune system disorder—Mesalazine—Crohn's disease	0.000199	0.00154	CcSEcCtD
Ofloxacin—Mediastinal disorder—Mesalazine—Crohn's disease	0.000198	0.00154	CcSEcCtD
Ofloxacin—Chills—Mesalazine—Crohn's disease	0.000197	0.00153	CcSEcCtD
Ofloxacin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000197	0.00153	CcSEcCtD
Ofloxacin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000195	0.00151	CcSEcCtD
Ofloxacin—Alopecia—Mesalazine—Crohn's disease	0.000194	0.00151	CcSEcCtD
Ofloxacin—Thrombophlebitis—Prednisone—Crohn's disease	0.000194	0.00151	CcSEcCtD
Ofloxacin—Anaemia—Azathioprine—Crohn's disease	0.000194	0.00151	CcSEcCtD
Ofloxacin—Diabetes mellitus—Prednisone—Crohn's disease	0.000193	0.0015	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000193	0.0075	CbGpPWpGaD
Ofloxacin—Mental disorder—Mesalazine—Crohn's disease	0.000193	0.00149	CcSEcCtD
Ofloxacin—Erythema—Mesalazine—Crohn's disease	0.000191	0.00148	CcSEcCtD
Ofloxacin—Malaise—Azathioprine—Crohn's disease	0.000189	0.00147	CcSEcCtD
Ofloxacin—Flatulence—Mesalazine—Crohn's disease	0.000189	0.00146	CcSEcCtD
Ofloxacin—Leukopenia—Azathioprine—Crohn's disease	0.000188	0.00146	CcSEcCtD
Ofloxacin—Vascular purpura—Prednisone—Crohn's disease	0.000188	0.00146	CcSEcCtD
Ofloxacin—Tension—Mesalazine—Crohn's disease	0.000188	0.00146	CcSEcCtD
Ofloxacin—Dysgeusia—Mesalazine—Crohn's disease	0.000187	0.00145	CcSEcCtD
Ofloxacin—Nervousness—Mesalazine—Crohn's disease	0.000186	0.00144	CcSEcCtD
Ofloxacin—Back pain—Mesalazine—Crohn's disease	0.000185	0.00144	CcSEcCtD
Ofloxacin—Muscle spasms—Mesalazine—Crohn's disease	0.000184	0.00143	CcSEcCtD
Ofloxacin—Vomiting—Mercaptopurine—Crohn's disease	0.000183	0.00142	CcSEcCtD
Ofloxacin—Rash—Mercaptopurine—Crohn's disease	0.000181	0.00141	CcSEcCtD
Ofloxacin—Dermatitis—Mercaptopurine—Crohn's disease	0.000181	0.00141	CcSEcCtD
Ofloxacin—Vision blurred—Mesalazine—Crohn's disease	0.00018	0.0014	CcSEcCtD
Ofloxacin—Tremor—Mesalazine—Crohn's disease	0.000179	0.00139	CcSEcCtD
Ofloxacin—Amnesia—Prednisone—Crohn's disease	0.000179	0.00139	CcSEcCtD
Ofloxacin—Arthralgia—Azathioprine—Crohn's disease	0.000179	0.00139	CcSEcCtD
Ofloxacin—Myalgia—Azathioprine—Crohn's disease	0.000179	0.00139	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000178	0.00138	CcSEcCtD
Ofloxacin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000178	0.00138	CcSEcCtD
Ofloxacin—Anaemia—Mesalazine—Crohn's disease	0.000177	0.00137	CcSEcCtD
Ofloxacin—Discomfort—Azathioprine—Crohn's disease	0.000177	0.00137	CcSEcCtD
Ofloxacin—Angioedema—Mesalazine—Crohn's disease	0.000175	0.00136	CcSEcCtD
Ofloxacin—Purpura—Prednisone—Crohn's disease	0.000174	0.00135	CcSEcCtD
Ofloxacin—Malaise—Mesalazine—Crohn's disease	0.000173	0.00134	CcSEcCtD
Ofloxacin—Cardiac failure—Prednisone—Crohn's disease	0.000172	0.00134	CcSEcCtD
Ofloxacin—Vertigo—Mesalazine—Crohn's disease	0.000172	0.00133	CcSEcCtD
Ofloxacin—Syncope—Mesalazine—Crohn's disease	0.000172	0.00133	CcSEcCtD
Ofloxacin—Leukopenia—Mesalazine—Crohn's disease	0.000171	0.00133	CcSEcCtD
Ofloxacin—Nausea—Mercaptopurine—Crohn's disease	0.000171	0.00133	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00017	0.00663	CbGpPWpGaD
Ofloxacin—Infection—Azathioprine—Crohn's disease	0.00017	0.00132	CcSEcCtD
Ofloxacin—Palpitations—Mesalazine—Crohn's disease	0.000169	0.00131	CcSEcCtD
Ofloxacin—Loss of consciousness—Mesalazine—Crohn's disease	0.000168	0.0013	CcSEcCtD
Ofloxacin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000168	0.0013	CcSEcCtD
Ofloxacin—Osteoarthritis—Prednisone—Crohn's disease	0.000168	0.0013	CcSEcCtD
Ofloxacin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000168	0.0013	CcSEcCtD
Ofloxacin—Cough—Mesalazine—Crohn's disease	0.000167	0.0013	CcSEcCtD
Ofloxacin—Skin disorder—Azathioprine—Crohn's disease	0.000167	0.00129	CcSEcCtD
Ofloxacin—Affect lability—Prednisone—Crohn's disease	0.000166	0.00128	CcSEcCtD
Ofloxacin—Hypertension—Mesalazine—Crohn's disease	0.000165	0.00128	CcSEcCtD
Ofloxacin—Psychotic disorder—Prednisone—Crohn's disease	0.000164	0.00127	CcSEcCtD
Ofloxacin—Chest pain—Mesalazine—Crohn's disease	0.000163	0.00126	CcSEcCtD
Ofloxacin—Myalgia—Mesalazine—Crohn's disease	0.000163	0.00126	CcSEcCtD
Ofloxacin—Arthralgia—Mesalazine—Crohn's disease	0.000163	0.00126	CcSEcCtD
Ofloxacin—Anxiety—Mesalazine—Crohn's disease	0.000162	0.00126	CcSEcCtD
Ofloxacin—Face oedema—Prednisone—Crohn's disease	0.000162	0.00126	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000162	0.00126	CcSEcCtD
Ofloxacin—Discomfort—Mesalazine—Crohn's disease	0.000161	0.00125	CcSEcCtD
Ofloxacin—Hypotension—Azathioprine—Crohn's disease	0.00016	0.00124	CcSEcCtD
Ofloxacin—Cardiac arrest—Prednisone—Crohn's disease	0.00016	0.00124	CcSEcCtD
Ofloxacin—Dry mouth—Mesalazine—Crohn's disease	0.000159	0.00124	CcSEcCtD
Ofloxacin—Mood swings—Prednisone—Crohn's disease	0.000159	0.00124	CcSEcCtD
Ofloxacin—Confusional state—Mesalazine—Crohn's disease	0.000158	0.00122	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000156	0.00121	CcSEcCtD
Ofloxacin—Anaphylactic shock—Mesalazine—Crohn's disease	0.000156	0.00121	CcSEcCtD
Ofloxacin—Oedema—Mesalazine—Crohn's disease	0.000156	0.00121	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000155	0.00604	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000155	0.00604	CbGpPWpGaD
Ofloxacin—Infection—Mesalazine—Crohn's disease	0.000155	0.0012	CcSEcCtD
Ofloxacin—Dry skin—Prednisone—Crohn's disease	0.000154	0.0012	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000154	0.00599	CbGpPWpGaD
Ofloxacin—Shock—Mesalazine—Crohn's disease	0.000154	0.00119	CcSEcCtD
Ofloxacin—Nervous system disorder—Mesalazine—Crohn's disease	0.000153	0.00119	CcSEcCtD
Ofloxacin—Hypokalaemia—Prednisone—Crohn's disease	0.000153	0.00119	CcSEcCtD
Ofloxacin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000153	0.00119	CcSEcCtD
Ofloxacin—Tachycardia—Mesalazine—Crohn's disease	0.000152	0.00118	CcSEcCtD
Ofloxacin—Skin disorder—Mesalazine—Crohn's disease	0.000152	0.00118	CcSEcCtD
Ofloxacin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000151	0.00117	CcSEcCtD
Ofloxacin—Anorexia—Mesalazine—Crohn's disease	0.000149	0.00115	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000148	0.00115	CcSEcCtD
Ofloxacin—Abdominal distension—Prednisone—Crohn's disease	0.000146	0.00113	CcSEcCtD
Ofloxacin—Hypotension—Mesalazine—Crohn's disease	0.000146	0.00113	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000145	0.00564	CbGpPWpGaD
Ofloxacin—Pancreatitis—Prednisone—Crohn's disease	0.000142	0.00111	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000142	0.0011	CcSEcCtD
Ofloxacin—Sweating increased—Prednisone—Crohn's disease	0.000142	0.0011	CcSEcCtD
Ofloxacin—Feeling abnormal—Azathioprine—Crohn's disease	0.000141	0.0011	CcSEcCtD
Ofloxacin—Insomnia—Mesalazine—Crohn's disease	0.000141	0.0011	CcSEcCtD
Ofloxacin—Paraesthesia—Mesalazine—Crohn's disease	0.00014	0.00109	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00014	0.00109	CcSEcCtD
Ofloxacin—Dyspnoea—Mesalazine—Crohn's disease	0.000139	0.00108	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000139	0.00541	CbGpPWpGaD
Ofloxacin—Somnolence—Mesalazine—Crohn's disease	0.000139	0.00108	CcSEcCtD
Ofloxacin—Dyspepsia—Mesalazine—Crohn's disease	0.000137	0.00107	CcSEcCtD
Ofloxacin—Neutropenia—Prednisone—Crohn's disease	0.000136	0.00105	CcSEcCtD
Ofloxacin—Decreased appetite—Mesalazine—Crohn's disease	0.000136	0.00105	CcSEcCtD
Ofloxacin—Body temperature increased—Azathioprine—Crohn's disease	0.000136	0.00105	CcSEcCtD
Ofloxacin—Abdominal pain—Azathioprine—Crohn's disease	0.000136	0.00105	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000135	0.00105	CcSEcCtD
Ofloxacin—Fatigue—Mesalazine—Crohn's disease	0.000135	0.00104	CcSEcCtD
Ofloxacin—Erectile dysfunction—Prednisone—Crohn's disease	0.000134	0.00104	CcSEcCtD
Ofloxacin—Constipation—Mesalazine—Crohn's disease	0.000134	0.00104	CcSEcCtD
Ofloxacin—Pain—Mesalazine—Crohn's disease	0.000134	0.00104	CcSEcCtD
Ofloxacin—Weight decreased—Prednisone—Crohn's disease	0.000131	0.00102	CcSEcCtD
Ofloxacin—Hyperglycaemia—Prednisone—Crohn's disease	0.000131	0.00102	CcSEcCtD
Ofloxacin—Feeling abnormal—Mesalazine—Crohn's disease	0.000129	0.000998	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000128	0.00499	CbGpPWpGaD
Ofloxacin—Acute coronary syndrome—Prednisone—Crohn's disease	0.000128	0.000991	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000128	0.000991	CcSEcCtD
Ofloxacin—Myocardial infarction—Prednisone—Crohn's disease	0.000127	0.000985	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000127	0.000985	CcSEcCtD
Ofloxacin—Hypersensitivity—Azathioprine—Crohn's disease	0.000126	0.00098	CcSEcCtD
Ofloxacin—Urticaria—Mesalazine—Crohn's disease	0.000124	0.000962	CcSEcCtD
Ofloxacin—Abdominal pain—Mesalazine—Crohn's disease	0.000123	0.000958	CcSEcCtD
Ofloxacin—Body temperature increased—Mesalazine—Crohn's disease	0.000123	0.000958	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000122	0.00474	CbGpPWpGaD
Ofloxacin—Bradycardia—Prednisone—Crohn's disease	0.000118	0.000918	CcSEcCtD
Ofloxacin—Diarrhoea—Azathioprine—Crohn's disease	0.000117	0.00091	CcSEcCtD
Ofloxacin—Haemoglobin—Prednisone—Crohn's disease	0.000117	0.000907	CcSEcCtD
Ofloxacin—Haemorrhage—Prednisone—Crohn's disease	0.000116	0.000902	CcSEcCtD
Ofloxacin—Hallucination—Prednisone—Crohn's disease	0.000116	0.000898	CcSEcCtD
Ofloxacin—Hypersensitivity—Mesalazine—Crohn's disease	0.000115	0.000893	CcSEcCtD
Ofloxacin—Connective tissue disorder—Prednisone—Crohn's disease	0.000114	0.000887	CcSEcCtD
Ofloxacin—Dizziness—Azathioprine—Crohn's disease	0.000113	0.00088	CcSEcCtD
Ofloxacin—Asthenia—Mesalazine—Crohn's disease	0.000112	0.000869	CcSEcCtD
Ofloxacin—Pruritus—Mesalazine—Crohn's disease	0.000111	0.000857	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000109	0.00426	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000109	0.00424	CbGpPWpGaD
Ofloxacin—Vomiting—Azathioprine—Crohn's disease	0.000109	0.000846	CcSEcCtD
Ofloxacin—Eye disorder—Prednisone—Crohn's disease	0.000109	0.000843	CcSEcCtD
Ofloxacin—Rash—Azathioprine—Crohn's disease	0.000108	0.000839	CcSEcCtD
Ofloxacin—Dermatitis—Azathioprine—Crohn's disease	0.000108	0.000838	CcSEcCtD
Ofloxacin—Flushing—Prednisone—Crohn's disease	0.000108	0.000837	CcSEcCtD
Ofloxacin—Headache—Azathioprine—Crohn's disease	0.000107	0.000833	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000107	0.00418	CbGpPWpGaD
Ofloxacin—Diarrhoea—Mesalazine—Crohn's disease	0.000107	0.000829	CcSEcCtD
Ofloxacin—Angiopathy—Prednisone—Crohn's disease	0.000106	0.000819	CcSEcCtD
Ofloxacin—Immune system disorder—Prednisone—Crohn's disease	0.000105	0.000815	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000105	0.00407	CbGpPWpGaD
Ofloxacin—Arrhythmia—Prednisone—Crohn's disease	0.000104	0.000806	CcSEcCtD
Ofloxacin—Dizziness—Mesalazine—Crohn's disease	0.000103	0.000801	CcSEcCtD
Ofloxacin—Alopecia—Prednisone—Crohn's disease	0.000103	0.000797	CcSEcCtD
Ofloxacin—Mental disorder—Prednisone—Crohn's disease	0.000102	0.00079	CcSEcCtD
Ofloxacin—Nausea—Azathioprine—Crohn's disease	0.000102	0.00079	CcSEcCtD
Ofloxacin—Malnutrition—Prednisone—Crohn's disease	0.000101	0.000785	CcSEcCtD
Ofloxacin—Erythema—Prednisone—Crohn's disease	0.000101	0.000785	CcSEcCtD
Ofloxacin—Vomiting—Mesalazine—Crohn's disease	9.93e-05	0.00077	CcSEcCtD
Ofloxacin—Rash—Mesalazine—Crohn's disease	9.85e-05	0.000764	CcSEcCtD
Ofloxacin—Dermatitis—Mesalazine—Crohn's disease	9.84e-05	0.000763	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.8e-05	0.00381	CbGpPWpGaD
Ofloxacin—Headache—Mesalazine—Crohn's disease	9.79e-05	0.000759	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	9.67e-05	0.00376	CbGpPWpGaD
Ofloxacin—Vision blurred—Prednisone—Crohn's disease	9.54e-05	0.00074	CcSEcCtD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	9.49e-05	0.00369	CbGpPWpGaD
Ofloxacin—Ill-defined disorder—Prednisone—Crohn's disease	9.4e-05	0.000729	CcSEcCtD
Ofloxacin—Anaemia—Prednisone—Crohn's disease	9.36e-05	0.000726	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	9.34e-05	0.00364	CbGpPWpGaD
Ofloxacin—Agitation—Prednisone—Crohn's disease	9.31e-05	0.000722	CcSEcCtD
Ofloxacin—Nausea—Mesalazine—Crohn's disease	9.28e-05	0.00072	CcSEcCtD
Ofloxacin—Angioedema—Prednisone—Crohn's disease	9.25e-05	0.000718	CcSEcCtD
Ofloxacin—Malaise—Prednisone—Crohn's disease	9.13e-05	0.000708	CcSEcCtD
Ofloxacin—Vertigo—Prednisone—Crohn's disease	9.1e-05	0.000706	CcSEcCtD
Ofloxacin—Syncope—Prednisone—Crohn's disease	9.08e-05	0.000704	CcSEcCtD
Ofloxacin—Loss of consciousness—Prednisone—Crohn's disease	8.9e-05	0.00069	CcSEcCtD
Ofloxacin—Hypertension—Prednisone—Crohn's disease	8.74e-05	0.000678	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.66e-05	0.00337	CbGpPWpGaD
Ofloxacin—Myalgia—Prednisone—Crohn's disease	8.62e-05	0.000669	CcSEcCtD
Ofloxacin—Arthralgia—Prednisone—Crohn's disease	8.62e-05	0.000669	CcSEcCtD
Ofloxacin—Anxiety—Prednisone—Crohn's disease	8.59e-05	0.000666	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	8.56e-05	0.000664	CcSEcCtD
Ofloxacin—Discomfort—Prednisone—Crohn's disease	8.52e-05	0.000661	CcSEcCtD
Ofloxacin—Oedema—Prednisone—Crohn's disease	8.26e-05	0.000641	CcSEcCtD
Ofloxacin—Anaphylactic shock—Prednisone—Crohn's disease	8.26e-05	0.000641	CcSEcCtD
Ofloxacin—Infection—Prednisone—Crohn's disease	8.21e-05	0.000637	CcSEcCtD
Ofloxacin—Shock—Prednisone—Crohn's disease	8.13e-05	0.000631	CcSEcCtD
Ofloxacin—Nervous system disorder—Prednisone—Crohn's disease	8.1e-05	0.000629	CcSEcCtD
Ofloxacin—Tachycardia—Prednisone—Crohn's disease	8.07e-05	0.000626	CcSEcCtD
Ofloxacin—Skin disorder—Prednisone—Crohn's disease	8.03e-05	0.000623	CcSEcCtD
Ofloxacin—Hyperhidrosis—Prednisone—Crohn's disease	7.99e-05	0.00062	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.94e-05	0.00309	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.89e-05	0.00307	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.89e-05	0.00307	CbGpPWpGaD
Ofloxacin—Anorexia—Prednisone—Crohn's disease	7.88e-05	0.000611	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.64e-05	0.00297	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.64e-05	0.00297	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.55e-05	0.00294	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.55e-05	0.00294	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Prednisone—Crohn's disease	7.53e-05	0.000584	CcSEcCtD
Ofloxacin—Insomnia—Prednisone—Crohn's disease	7.47e-05	0.00058	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisone—Crohn's disease	7.42e-05	0.000576	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.36e-05	0.00287	CbGpPWpGaD
Ofloxacin—Dyspepsia—Prednisone—Crohn's disease	7.27e-05	0.000564	CcSEcCtD
Ofloxacin—Decreased appetite—Prednisone—Crohn's disease	7.18e-05	0.000557	CcSEcCtD
Ofloxacin—Fatigue—Prednisone—Crohn's disease	7.13e-05	0.000553	CcSEcCtD
Ofloxacin—Constipation—Prednisone—Crohn's disease	7.07e-05	0.000548	CcSEcCtD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	7e-05	0.00272	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Prednisone—Crohn's disease	6.81e-05	0.000528	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Prednisone—Crohn's disease	6.76e-05	0.000524	CcSEcCtD
Ofloxacin—Urticaria—Prednisone—Crohn's disease	6.57e-05	0.000509	CcSEcCtD
Ofloxacin—Body temperature increased—Prednisone—Crohn's disease	6.53e-05	0.000507	CcSEcCtD
Ofloxacin—Abdominal pain—Prednisone—Crohn's disease	6.53e-05	0.000507	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.51e-05	0.00253	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	6.23e-05	0.00242	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.19e-05	0.00241	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.14e-05	0.00239	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Prednisone—Crohn's disease	6.09e-05	0.000472	CcSEcCtD
Ofloxacin—Asthenia—Prednisone—Crohn's disease	5.93e-05	0.00046	CcSEcCtD
Ofloxacin—Pruritus—Prednisone—Crohn's disease	5.85e-05	0.000453	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.8e-05	0.00226	CbGpPWpGaD
Ofloxacin—Diarrhoea—Prednisone—Crohn's disease	5.65e-05	0.000439	CcSEcCtD
Ofloxacin—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	5.65e-05	0.0022	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—UBE2D1—Crohn's disease	5.57e-05	0.00217	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.56e-05	0.00216	CbGpPWpGaD
Ofloxacin—Dizziness—Prednisone—Crohn's disease	5.47e-05	0.000424	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.39e-05	0.0021	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.38e-05	0.0021	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.32e-05	0.00207	CbGpPWpGaD
Ofloxacin—Vomiting—Prednisone—Crohn's disease	5.25e-05	0.000408	CcSEcCtD
Ofloxacin—Rash—Prednisone—Crohn's disease	5.21e-05	0.000404	CcSEcCtD
Ofloxacin—Dermatitis—Prednisone—Crohn's disease	5.21e-05	0.000404	CcSEcCtD
Ofloxacin—Headache—Prednisone—Crohn's disease	5.18e-05	0.000402	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.91e-05	0.00191	CbGpPWpGaD
Ofloxacin—Nausea—Prednisone—Crohn's disease	4.91e-05	0.000381	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.76e-05	0.00185	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.7e-05	0.00183	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	4.62e-05	0.0018	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.61e-05	0.0018	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	4.43e-05	0.00172	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RSPO3—Crohn's disease	4.34e-05	0.00169	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLA2G4F—Crohn's disease	4.16e-05	0.00162	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.14e-05	0.00161	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	4.12e-05	0.0016	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SEL1L—Crohn's disease	4.12e-05	0.0016	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—LTF—Crohn's disease	3.69e-05	0.00144	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.64e-05	0.00142	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.55e-05	0.00138	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTMR3—Crohn's disease	3.54e-05	0.00138	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.48e-05	0.00136	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—Crohn's disease	3.12e-05	0.00121	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.02e-05	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.99e-05	0.00116	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.99e-05	0.00116	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—GCKR—Crohn's disease	2.98e-05	0.00116	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—Crohn's disease	2.82e-05	0.0011	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—FADS1—Crohn's disease	2.76e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC11A1—Crohn's disease	2.63e-05	0.00102	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GPX4—Crohn's disease	2.58e-05	0.001	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GCKR—Crohn's disease	2.49e-05	0.00097	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.35e-05	0.000915	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.34e-05	0.000912	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RBX1—Crohn's disease	2.26e-05	0.000878	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HSPA1B—Crohn's disease	2.26e-05	0.000878	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.2e-05	0.000857	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—UBE2D1—Crohn's disease	1.98e-05	0.00077	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.78e-05	0.000693	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.77e-05	0.000689	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.71e-05	0.000667	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.69e-05	0.000659	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.58e-05	0.000615	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.56e-05	0.000607	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SMAD3—Crohn's disease	1.42e-05	0.000551	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.34e-05	0.000523	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—FADS1—Crohn's disease	1.05e-05	0.000407	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GPX4—Crohn's disease	9.8e-06	0.000381	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GCKR—Crohn's disease	9.47e-06	0.000368	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TYK2—Crohn's disease	9.23e-06	0.000359	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JAK2—Crohn's disease	8.81e-06	0.000343	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—Crohn's disease	8.35e-06	0.000325	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—Crohn's disease	8.29e-06	0.000323	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—Crohn's disease	7.93e-06	0.000309	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—Crohn's disease	6.94e-06	0.00027	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.77e-06	0.000263	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—Crohn's disease	6.46e-06	0.000252	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.92e-06	0.00023	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—Crohn's disease	4.51e-06	0.000176	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—Crohn's disease	3.01e-06	0.000117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.64e-06	0.000103	CbGpPWpGaD
